
Savitha M. Rao
Examiner (ID: 10492, Phone: (571)270-5315 , Office: P/1621 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1614, 1621, 1691, 4131 |
| Total Applications | 1525 |
| Issued Applications | 872 |
| Pending Applications | 108 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9034850
[patent_doc_number] => 20130237488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-12
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY BOWEL DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/722395
[patent_app_country] => US
[patent_app_date] => 2012-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9716
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13722395
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/722395 | Methods and compositions for treating inflammatory bowel disease | Dec 19, 2012 | Issued |
Array
(
[id] => 8767014
[patent_doc_number] => 20130095051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA'
[patent_app_type] => utility
[patent_app_number] => 13/707140
[patent_app_country] => US
[patent_app_date] => 2012-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2497
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13707140
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/707140 | AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA | Dec 5, 2012 | Abandoned |
Array
(
[id] => 9772635
[patent_doc_number] => 20140296298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'COMPOSITION AND METHOD FOR CONTROLLING HARMFUL ARTHROPODS'
[patent_app_type] => utility
[patent_app_number] => 14/350172
[patent_app_country] => US
[patent_app_date] => 2012-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5239
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350172
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350172 | Composition and method for controlling harmful arthropods | Dec 4, 2012 | Issued |
Array
(
[id] => 9699501
[patent_doc_number] => 20140249187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-04
[patent_title] => 'COMPOSITION AND METHOD FOR CONTROLLING HARMFUL ARTHROPODS'
[patent_app_type] => utility
[patent_app_number] => 14/350183
[patent_app_country] => US
[patent_app_date] => 2012-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4973
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350183
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350183 | Composition and method for controlling harmful arthropods | Dec 4, 2012 | Issued |
Array
(
[id] => 10514456
[patent_doc_number] => 09241485
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-26
[patent_title] => 'Composition and method for controlling harmful arthropods'
[patent_app_type] => utility
[patent_app_number] => 14/350177
[patent_app_country] => US
[patent_app_date] => 2012-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5192
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350177
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350177 | Composition and method for controlling harmful arthropods | Dec 4, 2012 | Issued |
Array
(
[id] => 10906237
[patent_doc_number] => 20140309250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-16
[patent_title] => 'Pharmaceutical Formulations'
[patent_app_type] => utility
[patent_app_number] => 14/359121
[patent_app_country] => US
[patent_app_date] => 2012-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2573
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14359121
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/359121 | Pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate | Nov 20, 2012 | Issued |
Array
(
[id] => 8734126
[patent_doc_number] => 20130079695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-28
[patent_title] => 'HEMOSTATIC SPONGE'
[patent_app_type] => utility
[patent_app_number] => 13/682085
[patent_app_country] => US
[patent_app_date] => 2012-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7341
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13682085
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/682085 | Hemostatic sponge | Nov 19, 2012 | Issued |
Array
(
[id] => 10940091
[patent_doc_number] => 20140343112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'USE OF AMINO ACID SUPPLEMENTATION FOR IMPROVED MUSCLE RECOVERY'
[patent_app_type] => utility
[patent_app_number] => 14/359213
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7501
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14359213
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/359213 | Use of amino acid supplementation for improved muscle recovery | Nov 18, 2012 | Issued |
Array
(
[id] => 10265995
[patent_doc_number] => 20150150992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'COMPOSITION FOR THE PHOTODYNAMIC DIAGNOSIS AND THERAPY OF TUMOURS'
[patent_app_type] => utility
[patent_app_number] => 14/356901
[patent_app_country] => US
[patent_app_date] => 2012-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3222
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14356901
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/356901 | Composition of chlorin e6 stabilized within albumin for the photodynamic diagnosis and therapy of tumors | Nov 6, 2012 | Issued |
Array
(
[id] => 9450108
[patent_doc_number] => 20140121278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'ANTI-TUMOR AGENT OTX-008 TARGETS HUMAN GALECTIN-1'
[patent_app_type] => utility
[patent_app_number] => 13/666085
[patent_app_country] => US
[patent_app_date] => 2012-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20806
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13666085
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/666085 | ANTI-TUMOR AGENT OTX-008 TARGETS HUMAN GALECTIN-1 | Oct 31, 2012 | Abandoned |
Array
(
[id] => 9323182
[patent_doc_number] => 08658200
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-25
[patent_title] => 'Flavoring of drug-containing chewing gums'
[patent_app_type] => utility
[patent_app_number] => 13/662517
[patent_app_country] => US
[patent_app_date] => 2012-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6629
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13662517
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/662517 | Flavoring of drug-containing chewing gums | Oct 27, 2012 | Issued |
Array
(
[id] => 10147843
[patent_doc_number] => 09180108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-10
[patent_title] => 'Baclofen formulations and methods for making same'
[patent_app_type] => utility
[patent_app_number] => 13/661800
[patent_app_country] => US
[patent_app_date] => 2012-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 10035
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13661800
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/661800 | Baclofen formulations and methods for making same | Oct 25, 2012 | Issued |
Array
(
[id] => 9483117
[patent_doc_number] => 08729068
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-20
[patent_title] => 'Tetrahydrobenzothiophene compound'
[patent_app_type] => utility
[patent_app_number] => 13/661545
[patent_app_country] => US
[patent_app_date] => 2012-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25586
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13661545
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/661545 | Tetrahydrobenzothiophene compound | Oct 25, 2012 | Issued |
Array
(
[id] => 8721287
[patent_doc_number] => 20130072505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => '6,9-Disubstituted Purine Derivatives and Their Use for Treating Skin'
[patent_app_type] => utility
[patent_app_number] => 13/630673
[patent_app_country] => US
[patent_app_date] => 2012-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16022
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13630673
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/630673 | 6,9-Disubstituted Purine Derivatives and Their Use for Treating Skin | Sep 27, 2012 | Abandoned |
Array
(
[id] => 8649664
[patent_doc_number] => 20130035394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-07
[patent_title] => 'Calixarene-Based Peptide Conformation Mimetics, Methods of Use, and Methods of Making'
[patent_app_type] => utility
[patent_app_number] => 13/630394
[patent_app_country] => US
[patent_app_date] => 2012-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 32102
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13630394
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/630394 | Calixarene-based peptide conformation mimetics, methods of use, and methods of making | Sep 27, 2012 | Issued |
Array
(
[id] => 8607273
[patent_doc_number] => 20130012584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'Tranexamic Acid Formulations'
[patent_app_type] => utility
[patent_app_number] => 13/620148
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17145
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13620148
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/620148 | Tranexamic acid formulations | Sep 13, 2012 | Issued |
Array
(
[id] => 9620987
[patent_doc_number] => 08791160
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-29
[patent_title] => 'Tranexamic acid formulations'
[patent_app_type] => utility
[patent_app_number] => 13/620226
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 17141
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13620226
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/620226 | Tranexamic acid formulations | Sep 13, 2012 | Issued |
Array
(
[id] => 10031360
[patent_doc_number] => 09072660
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Topical itraconazole formulations and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/607489
[patent_app_country] => US
[patent_app_date] => 2012-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7399
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13607489
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/607489 | Topical itraconazole formulations and uses thereof | Sep 6, 2012 | Issued |
Array
(
[id] => 8981630
[patent_doc_number] => 08512743
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-20
[patent_title] => 'Devices and methods for the delivery of molecular sieve materials for the formation of blood clots'
[patent_app_type] => utility
[patent_app_number] => 13/598381
[patent_app_country] => US
[patent_app_date] => 2012-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 3415
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13598381
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/598381 | Devices and methods for the delivery of molecular sieve materials for the formation of blood clots | Aug 28, 2012 | Issued |
Array
(
[id] => 8660503
[patent_doc_number] => 20130041332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'DEVICES AND METHODS FOR THE DELIVERY OF BLOOD CLOTTING MATERIALS TO BLEEDING WOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/595932
[patent_app_country] => US
[patent_app_date] => 2012-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4456
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13595932
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/595932 | Devices and methods for the delivery of blood clotting materials to bleeding wounds | Aug 26, 2012 | Issued |